Puma Biotechnology (PBYI) EPS (Basic) (2017 - 2025)
Historic EPS (Basic) for Puma Biotechnology (PBYI) over the last 9 years, with Q3 2025 value amounting to $0.18.
- Puma Biotechnology's EPS (Basic) fell 5609.76% to $0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.75, marking a year-over-year increase of 5625.0%. This contributed to the annual value of $0.48 for FY2024, which is 368.48% up from last year.
- As of Q3 2025, Puma Biotechnology's EPS (Basic) stood at $0.18, which was down 5609.76% from $0.12 recorded in Q2 2025.
- Puma Biotechnology's 5-year EPS (Basic) high stood at $0.41 for Q1 2021, and its period low was -$1.09 during Q3 2021.
- In the last 5 years, Puma Biotechnology's EPS (Basic) had a median value of $0.06 in 2025 and averaged $0.03.
- In the last 5 years, Puma Biotechnology's EPS (Basic) skyrocketed by 130000.0% in 2023 and then tumbled by 43333.33% in 2024.
- Over the past 5 years, Puma Biotechnology's EPS (Basic) (Quarter) stood at $0.1 in 2021, then plummeted by 225.49% to -$0.13 in 2022, then soared by 307.2% to $0.26 in 2023, then decreased by 3.31% to $0.25 in 2024, then fell by 28.4% to $0.18 in 2025.
- Its EPS (Basic) stands at $0.18 for Q3 2025, versus $0.12 for Q2 2025 and $0.06 for Q1 2025.